Skip to content

Clinical trials

Immune System Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Country / region: South Korea Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20162
20181
20191
20202
20222
20234
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting5
Active, not recruiting4
Terminated4
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
GlaxoSmithKline2
Novartis Pharmaceuticals2
Pfizer2
Takeda2
Viatris Innovation GmbH2
Alumis Inc1
Ariad Pharmaceuticals1
Biogen1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases20
Autoimmune Diseases12
Connective Tissue Diseases7
Lupus Erythematosus, Systemic6
Dermatitis3
Dermatitis, Atopic3
Eczema3
Glomerulonephritis3
Glomerulonephritis, IGA3
Hematologic Diseases3

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.